FDA
-
-
-
-
-
-
-
Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 Million
-
-
-
-
-
-
-
Sensus Healthcare Signs Exclusive U.S. Distribution Agreement with Mattioli Eng. Italia for its TransDermal Infusion System
-
-
-
-
-
-
-
Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World's First Sculpturaâ„¢ Intraoperative Radiation Therapy System
-
-
-
-
-
-
-
Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars
-
-
-
-
-
-
-
Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

